Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils ID6235

Draft guidance: 1

Public committee slides (PowerPoint 1.83 MB)

Equality impact assessment (downloadable version) (PDF 120 KB)

Draft guidance (downloadable version) (PDF 263 KB)

Committee papers (PDF 8.55 MB)

Final scope (PDF 201 KB)

Equality impact assessment (scoping) (PDF 126 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 547 KB)

Draft scope post referral (PDF 176 KB)